This suggests that SLE patients are capable of overcoming IR in peripheral tissues, preserving glucose uptake at the expense of increased fasting and postprandial insulin secretion, which could lead to β-cell dysfunction and T2D in the long run, increasing CVD risk (4). The gene discussed is INS; the disease is type 2 diabetes mellitus.